Isoxazoline compounds as 5-lipoxygenase inhibitors
US5696141A · kind A · utility
0Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 1996 |
| Grant date | Dec 9, 1997 |
| Priority date | — |
| Expiry date | Sep 5, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method of inhibiting 5-lipoxygenase in a mammal in need thereof by administering compounds of the core of formula ##STR1## the racemic, racemic-diastereomeric mixtures and optical isomers of said compounds and the pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.